IN PARTNERSHIP
any regulated study. It is important to discuss accountability and checks for compliance protocols across your selected sites. Schlesinger manages 30 proprietary sites
in key locations across the US and Europe. Management of these high-specification data collection and clinical testing spaces is integrated to ensure consistent site standards, service levels and protocols.
How are you able to ensure you recruit diverse populations? For your participants to reflect a diverse population, they must be recruited from a diverse pool. You need to discuss how your partner defines participant diversity and agree the level of demographic diversity desirable for your study. At Schlesinger, we have global access to over
ten million panellists. Our vast proprietary panels of opted-in consumers and patients support more than 250,000 participants in our clinical studies annually. Nationwide and global panels, along with
diverse online and offline recruiting methods, enable a wide respondent pool to collect your clinical data from. Preidentified therapeutic categories, conditions and ailments, along with demographics and behavioural profiles, allows us to quickly find your target participants.
How do you continue to ensure data security and participant privacy? This question applies now as much as it did before the pandemic: ensuring any new working methods or site changes have not impacted the security of your data or the participants’ right to privacy. Schlesinger’s internal control system has been
developed for the highest security of client and participant data during all stages of your study. Our data centre is ISO 27001 IT security standards-certified and we’re FDA CFR Part 11 compliant. Healthcare companies, government agencies and leading brands are among some of our clients that trust us to meet their clinical research needs, while guaranteeing their high specifications for security and compliance. This may be to ensure their particular patient privacy, conduct, GDPR or legal obligations are met, or it may be to protect highly sensitive product development activity. Whatever the motivation, in order to be selected to partner
with such companies, Schlesinger meets high-specification client briefs and undergoes stringent audits.
How are you able to manage projects to accelerate timelines in a pandemic? To manage our project timelines, we consider how our new environment might have impacted the speed at which the study can be completed. At Schlesinger, we help streamline clinical
research by accommodating sites, recruitment and protocols management under one roof. A dedicated and expert project leader ensures you only brief your study once and leave compliance in our hands. We liaise with our clinical recruiters and sites to ensure that they are fully prepared and compliant for study success. Our panel sampling, recruitment expertise and centralised management enable fast recruitment and retention results with timely and efficient participant collaboration.
How are you able to leverage technology to replace or complement in-person studies? When travel or in-person clinical research is not an option, be prepared to adopt online research methods and streaming solutions to meet your objectives. Many elements of clinical research require
on-site, in-person testing. However, online methods can often be the solution for alternative or complementary in-depth interviews, online surveys, online usability testing, digital ethnography and video diaries, for example. Online solutions also have
the benefits
of connecting with hard-to-reach types and targets for sensitive topics, and reaching far-flung global populations while capturing useful video data as well.
Schlesinger Group has high-performing
proprietary platforms that make it smarter, faster and easier to get the impactful data you need online. Of particular benefit to our clients is our ‘Over The Shoulder’ online ethnography tool, ideal for collecting detailed diary information and conducting mobile ethnographies. We are seeing clients plan successful hybrid solutions and we have the agility to seamlessly switch techniques at any point of your study, should any challenges impact your plan. ●
www.schlesingergroup.com Outsourcing in Clinical Trials Handbook | 21
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120
